-
公开(公告)号：KR100131515B1
公开(公告)日：1998-04-17
申请号：KR1019940010312
申请日：1994-05-11
Applicant: 주식회사대성미생물연구소
Abstract: The interaction between Ocytetracycline(OTC) and Tiamulin(TML) is measured by testing antibiotic effect of compound of OTC and TML at minimum inhibition concentration(MIC) to multi-resistant microorganism - gram positive and negative bacteria separated from chicken, pig and bull infected by several bacterial disease. Herein the medicines is produced by the mixing ratio between OTC and TML is 6:1-18:1 to each weight, inhibites the emergence of antibiotics resisting cluster and decreases the toxicity with decreasing amount when combination is inserted.
Abstract translation: 通过测试OTC和TML的化合物对从鸡，猪和牛感染分离的多重耐药微生物 - 革兰氏阳性和阴性细菌的抑制浓度（MIC）的最小抑制浓度（MIC）的抗生素效应，测量了四环素（OTC）和钛霉素（TML） 几种细菌性疾病。 本发明药物通过OTC与TML的混合比例为6：1-18：1，每次加入时可抑制抗生素抗生素的出现，并在插入组合时减少毒性。
-
公开(公告)号：KR1019970065705A
公开(公告)日：1997-10-13
申请号：KR1019960006817
申请日：1996-03-14
Applicant: 한국과학기술연구원 , 주식회사대성미생물연구소
IPC: C12N1/20
Abstract: 본 발명은 신균주 바실러스속 (Bacillus sp.) DS11(KCTC 0231BP)과 이로부터 생산되는 신규 파이타아제(Phytase)에 관한 것으로서, 더욱 상세하게는 신균주 바실러스속(Bacillus sp.)DS11과 단위가축에 급여하는 곡류내 인(P)의 체내이용성을 높여주는 신규한 파이타아제 효소에 관한 것이다.
-
公开(公告)号：KR1019920006107B1
公开(公告)日：1992-07-27
申请号：KR1019900011743
申请日：1990-07-31
Applicant: 주식회사대성미생물연구소
Inventor： 이동규
IPC: C12N7/04
Abstract: A method for extracting and purifying envelope glycoprotein of hog cholera virus (HCV) comprises: (a) fermenting HCV and concentrating, (b) adding 1.5-3 W/V% n-octyl-β-D-blucopyranoside, 0.5-2 V/V% polyoxyethylene sorbitan monolaurate or decanoyl-N-methylglucamide into the concentrated soln., and sonicating, (c) mixing the sonicated soln. with polyoxyethylene ether-100 or polyoxyethylene sorbitan monooleate, (d) reacting the mixt. at 50-60 deg.C for 2 hrs. in the shaker, and (e) concentrating the reacted mixt. and purifying. The obtd. envelope glycoprotein is useful for the protection of animals from HCV infection.
Abstract translation: 提取和纯化猪霍乱病毒（HCV）的包膜糖蛋白的方法包括：（a）发酵HCV并浓缩，（b）加入1.5-3W / V％正辛基-β-D-吡喃葡萄糖苷，0.5-2V / V％聚氧乙烯山梨糖醇酐单月桂酸酯或癸酰基-N-甲基葡糖酰胺加入到浓缩溶液中，并超声处理，（c）混合超声处理的溶胶。 与聚氧乙烯醚-100或聚氧乙烯山梨聚糖单油酸酯，（d）使混合物反应。 在50-60℃2小时。 在振动器中，和（e）浓缩反应的混合物。 并净化。 有限公司 包膜糖蛋白可用于保护动物免受HCV感染。
-
公开(公告)号：KR1019920009980A
公开(公告)日：1992-06-26
申请号：KR1019900018951
申请日：1990-11-22
Applicant: 주식회사대성미생물연구소
IPC: C12N7/04
Abstract: 내용 없음
-
-
Patent Agency Ranking
公开(公告)号：KR102086462B1
公开(公告)日：2020-03-09
申请号：KR1020180089678
申请日：2018-08-01
Applicant: 주식회사대성미생물연구소
IPC: A61K31/545 , A61K31/7056 , A61K31/66 , A61K31/4402 , A61P31/00
-
公开(公告)号：KR1020120117715A
公开(公告)日：2012-10-24
申请号：KR1020120109818
申请日：2012-10-04
Applicant: 주식회사대성미생물연구소
Inventor： 조항원
IPC: A61K31/573 , A61K31/66 , A61P31/00
CPC classification number: A61K31/573 , A61K9/0019 , A61K9/08 , A61K9/14 , A61K9/20 , A61K31/66 , A61K2300/00
Abstract: PURPOSE: A complex functional antibiotic composition for animals is provided to enhance safety and metabolism for penicillin anaphylaxis. CONSTITUTION: A complex functional antibiotic composition for animals comprises 0.5-5 parts by weight of dexamethasone and 0.05-0.5 parts by weight of butaphosphane based on 100 parts by weight of PPS antibiotic. The antibiotic composition contains 0.1-0.3 parts by weight of dexamethasone and 1-3 parts by weight of butaphosphane based on 100 parts by weight of the PPS antibiotic. The effects of the complex functional antibiotic composition are used for treating animal diseases caused by bacteria sensitive for penicillin and streptomycin including pneumonia of cattle, horses, pigs, sheep, goats, long-tailed goral, dogs and cats, pasteurellosis, diarrhea, mastitis, uteltis, leptospira, swine erysipelas, and sepsis.
Abstract translation: 目的：提供一种用于动物的复合功能性抗生素组合物，以增强青霉素过敏反应的安全性和新陈代谢。 构成：基于100重量份的PPS抗生素，用于动物的复合功能性抗生素组合物包含0.5-5重量份的地塞米松和0.05-0.5重量份的Butaphosphane。 基于100重量份的PPS抗生素，抗生素组合物含有0.1-0.3重量份的地塞米松和1-3重量份的偶氮烷。 复合功能性抗生素组合物的作用用于治疗对青霉素和链霉素敏感的细菌引起的动物疾病，包括牛，马，猪，绵羊，山羊，长尾狗，狗和猫的肺炎，巴斯德氏杆菌病，腹泻，乳腺炎， uteltis，钩端螺旋体，猪丹毒和败血症。
-
公开(公告)号：KR101092599B1
公开(公告)日：2011-12-13
申请号：KR1020080116967
申请日：2008-11-24
Applicant: 주식회사대성미생물연구소
IPC: A61K31/546 , A61K31/43 , A61K31/165
Abstract: 본 발명은 동물용 복합항생제 조성물에 관한 것으로서, 더욱 상세하게는 세팔로스포린계 항생물질로 알려진 세푸록심(Cefuroxime) 또는 베타-락탐계 항생물질인 아목시실린(Amoxicillin)과, 클로람페니콜계 항생물질인 플로르페니콜(Florfenicol)을 0.3 ~ 3 : 1 의 중량비로 복합 처방함으로써 단독 처방 시와 다른 항생물질의 복합항생제에 비해 어류 및 축산 세균에 대한 탁월한 항균 효과를 갖는 동물용 복합항생제 조성물에 관한 것이다.
세푸록심, 아목시실린, 플로르페니콜, 어류 및 축산 세균-
公开(公告)号：KR1020100006889A
公开(公告)日：2010-01-22
申请号：KR1020080067209
申请日：2008-07-10
Applicant: 주식회사대성미생물연구소
IPC: A61K31/545 , A61K31/498
CPC classification number: A61K31/545 , A61K9/06 , A61K9/16 , A61K31/496 , A61K2300/00
Abstract: PURPOSE: A complex antibiotics composition for animal administered with cephalexine and enrofloxacin is provided to reduce the amount of composition, prevent and treat mastitis. CONSTITUTION: A complex antibiotics composition for an animal contains cephalexine and enrofloxacin in a weight ratio of 1 : 0.25-0.25 : 1. The complex antibiotics is formulated with additive, powder, injection for animal, oral administration liquid or ointment. The additive and powder for animal containing the complex antibiotics contains vitamin, glucose, lactose, various powder and enzyme.
Abstract translation: 目的：提供用于动物给予头孢氨苄和恩氟沙星的复合抗生素组合物，以减少组合物的量，预防和治疗乳腺炎。 构成：动物复合抗生素组合物含有头孢氨苄和恩氟沙星，重量比为1:0.25-0.25:1。复合抗生素配合添加剂，粉剂，注射用于动物，口服液体或软膏。 含有复合抗生素的动物添加剂和粉末含有维生素，葡萄糖，乳糖，各种粉末和酶。
-
公开(公告)号：KR100358084B1
公开(公告)日：2002-10-25
申请号：KR1020000058222
申请日：2000-10-04
Applicant: 주식회사대성미생물연구소 , 김기홍
Inventor： 김기홍
IPC: A61K31/498
Abstract: 본 발명은 프라지콴텔(praziquantel)과 시메티딘(cimetidine) 합제를 이용한 어류의 아가미흡충증 치료방법에 관한 것으로서, 더욱 상세하게는 종래에 인체 및 수의동물의 항연충제로 사용되어지고 있는 프라지콴텔과 인체의 위, 십이지장궤양 치료제로 사용되어지고 있는 시메티딘을 합제로 사용하여 치료효율이 매우 미약한 실정에 있는 어류의 아가미흡충증에 적용시킴으로써, 경제적이고 치료효과를 극대화시키는 새로운 어류 아가미흡충증 치료방법에 관한 것이다.
-
-
-
-
-
-
-
-
-
Search Results
62
records
(took 0.019 seconds)
